BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15454253)

  • 1. Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group.
    Cacciavillano WD; Brugières L; Childs M; Shafford E; Brock P; Pritchard J; Mailbach R; Scopinaro M; Perilongo G
    Eur J Cancer; 2004 Oct; 40(15):2274-9. PubMed ID: 15454253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
    Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
    Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
    J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M; Gandola L; Spreafico F; Biassoni V; Luksch R; Collini P; Solero CN; Simonetti F; Pignoli E; Cefalo G; Poggi G; Modena P; Mariani L; Potepan P; Podda M; Casanova M; Pecori E; Acerno S; Ferrari A; Terenziani M; Meazza C; Polastri D; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1358-63. PubMed ID: 19019566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2000 Burkitt lymphoma trial in Malawi.
    Hesseling P; Broadhead R; Mansvelt E; Louw M; Wessels G; Borgstein E; Schneider J; Molyneux E
    Pediatr Blood Cancer; 2005 Mar; 44(3):245-50. PubMed ID: 15547922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin and doxorubicin (CARDOX) for nonmetastatic hepatoblastoma: a discouraging pilot study.
    Dall'Igna P; Cecchetto G; Dominici C; Donfrancesco A; Carli M; Indolfi P; Guglielmi M; Perilongo G
    Med Pediatr Oncol; 2001 Feb; 36(2):332-4. PubMed ID: 11452948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical observation on the treatment outcome of 14 children with hepatoblastoma in a single medical center].
    Pan C; Tang JY; Chen J; Xue HL; Dong L; Zhou M; Jiang H; Ye QD; Gu LJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Aug; 11(8):659-62. PubMed ID: 19695195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
    Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
    Kushner BH; Cheung IY; Kramer K; Modak S; Cheung NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):430-4. PubMed ID: 16421906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboplatin-epirubicin regimen for the treatment of hepatoblastoma.
    Blouin P; Brugières L; Tabone MD; Leverger G; Rubie H; Branchereau S; De Kraker J
    Pediatr Blood Cancer; 2004 Feb; 42(2):149-54. PubMed ID: 14752879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue.
    Kobrinsky NL; Sjolander DE; Goldenberg JA; Ortmeier TC
    Pediatr Blood Cancer; 2005 Aug; 45(2):222-5. PubMed ID: 15770640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.
    Perilongo G; Shafford E; Maibach R; Aronson D; Brugières L; Brock P; Childs M; Czauderna P; MacKinlay G; Otte JB; Pritchard J; Rondelli R; Scopinaro M; Staalman C; Plaschkes J;
    Eur J Cancer; 2004 Feb; 40(3):411-21. PubMed ID: 14746860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.
    Héry G; Franchi-Abella S; Habes D; Brugières L; Martelli H; Fabre M; Pariente D; Gauthier F; Jacquemin E; Branchereau S
    Pediatr Blood Cancer; 2011 Dec; 57(7):1270-5. PubMed ID: 21910210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
    Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
    N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
    Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
    Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
    Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
    Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
    Bernbeck B; Bahci S; Meisel R; Troeger A; Schönberger S; Laws HJ; Kramm C; Wessalowski R; Koscielniak E; Dilloo D; Göbel U
    Klin Padiatr; 2007; 219(6):318-22. PubMed ID: 18050041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.